An AAV capsid reprogrammed to bind human Transferrin Receptor mediates brain-wide gene delivery.
An AAV capsid reprogrammed to bind human Transferrin Receptor mediates brain-wide gene delivery.
复制标题
重新编程的 AAV 衣壳可结合人转铁蛋白受体,介导全脑基因传递。
DOI:
10.1101/2023.12.20.572615
复制
发表时间:
2023
期刊:
影响因子:
--
通讯作者:
Tobey,Isabel
中科院分区:
文献类型:
--
作者:
Huang,Qin;Chan,KenY;Lou,Shan;Keyes,Casey;Wu,Jason;Botticello-Romero,NuriaR;Zheng,Qingxia;Johnston,Jencilin;Mills,Allan;Brauer,PamelaP;Clouse,Gabrielle;Pacouret,Simon;Harvey,JohnW;Beddow,Thomas;Hurley,JennaK;Tobey,Isabel
Developing vehicles that efficiently deliver genes throughout the human central nervous system (CNS) will broaden the range of treatable genetic diseases. We engineered an adeno-associated virus (AAV) capsid, BI-hTFR1, that binds human transferrin receptor (TfR1), a protein expressed on the blood-brain barrier. BI-hTFR1 was actively transported across human brain endothelial cells and, relative to AAV9, provided 40 to 50 times greater reporter expression in the CNS of humanTFRCknockin mice. The enhanced tropism was CNS-specific and absent in wild-type mice. When used to deliverGBA1, mutations of which cause Gaucher disease and are linked to Parkinson’s disease, BI-hTFR1 substantially increased brain and cerebrospinal fluid glucocerebrosidase activity compared with AAV9. These findings establish BI-hTFR1 as a potential vector for human CNS gene therapy.